Free Trial

QuidelOrtho (QDEL) Stock Forecast & Price Target

$38.91
+0.67 (+1.75%)
(As of 07/26/2024 ET)

QuidelOrtho - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 7 Wall Street analysts who have issued ratings for QuidelOrtho in the last 12 months, the stock has a consensus rating of "Hold." Out of the 7 analysts, 2 have given a sell rating, 3 have given a hold rating, and 2 have given a buy rating for QDEL.

Consensus Price Target

$59.00
51.63% Upside
High Forecast$76.00
Average Forecast$59.00
Low Forecast$37.00

According to the 7 analysts' twelve-month price targets for QuidelOrtho, the average price target is $59.00. The highest price target for QDEL is $76.00, while the lowest price target for QDEL is $37.00. The average price target represents a forecasted upside of 51.63% from the current price of $38.91.

TypeCurrent Forecast
7/28/23 to 7/27/24
1 Month Ago
6/28/23 to 6/27/24
3 Months Ago
4/29/23 to 4/28/24
1 Year Ago
7/28/22 to 7/28/23
Consensus Rating
Hold
Hold
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
1 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
2 Buy rating(s)
Hold
3 Hold rating(s)
3 Hold rating(s)
3 Hold rating(s)
2 Hold rating(s)
Sell
2 Sell rating(s)
2 Sell rating(s)
2 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$59.00$59.00$61.60$123.83
Forecasted Upside51.63% Upside2.13% Upside6.17% Upside43.86% Upside
Get QuidelOrtho Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for QDEL and its competitors with MarketBeat's FREE daily newsletter.

QDEL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

QDEL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

QuidelOrtho Stock vs. The Competition

TypeQuidelOrthoMedical CompaniesS&P 500
Consensus Rating Score
2.00
2.72
2.50
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside51.63% Upside3,121.53% Upside9.09% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/9/2024Royal Bank of Canada
4 of 5 stars
 Lower TargetOutperform ➝ Outperform$81.00 ➝ $68.00+55.36%
3/4/2024UBS Group
4 of 5 stars
 Reiterated RatingNeutral ➝ Sell$70.00 ➝ $42.00-7.75%
2/14/2024Craig Hallum
4 of 5 stars
 Reiterated RatingBuy ➝ Hold
2/14/2024William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
A. Brackmann
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Market Perform
2/14/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingStrong-Buy ➝ Outperform$100.00 ➝ $76.00+13.82%
2/14/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight$66.00 ➝ $37.00-44.59%
12/11/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Neutral$95.00 ➝ $72.00+9.06%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:15 AM ET.

QDEL Forecast - Frequently Asked Questions

What is QuidelOrtho's forecast for 2024?

According to the research reports of 7 Wall Street equities research analysts, the average twelve-month stock price forecast for QuidelOrtho is $59.00, with a high forecast of $76.00 and a low forecast of $37.00.

Should I buy or sell QuidelOrtho stock right now?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for QuidelOrtho in the last year. There are currently 2 sell ratings, 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" QDEL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in QDEL, but not buy additional shares or sell existing shares.

Does QuidelOrtho's stock price have much upside?

According to analysts, QuidelOrtho's stock has a predicted upside of 2.13% based on their 12-month stock forecasts.

What analysts cover QuidelOrtho?

QuidelOrtho has been rated by research analysts at Royal Bank of Canada in the past 90 days.

Do Wall Street analysts like QuidelOrtho more than its competitors?

Analysts like QuidelOrtho less than other "medical" companies. The consensus rating for QuidelOrtho is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how QDEL compares to other companies.


This page (NASDAQ:QDEL) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners